Company Directory

Contract microbial whole genome sequencing and metagenomics service

MicrobesNG Ltd is a UK-based contract sequencing service provider specialising in microbial whole genome and metagenome sequencing. The company processes bacterial, fungal, and viral samples using Illumina short-read and Oxford Nanopore long-read platforms, with DNA extraction and bioinformatics analysis included as standard. Services are accessible to academic, public sector, and commercial customers across more than 40 countries.

Long-read RNA sequencing platform for cancer biomarker discovery and diagnostics

Wobble Genomics is a Scottish biotechnology company developing long-read RNA sequencing technologies for biomarker discovery and cancer diagnostics. Its core platform combines a biochemical method to enrich rare and low-abundance full-length RNA transcripts, with a bioinformatics pipeline for novel transcript identification. The company is building a clinical diagnostic platform for breast cancer detection using cell-free RNA liquid biopsy, with broader applications in oncology drug discovery and disease monitoring.

Next-generation sequencing and genomic analysis services

Novogene (UK) is a genomic services provider operating as the European hub of Novogene Corporation, one of the world's largest sequencing organisations. Based at Cambridge Science Park, the company offers a comprehensive range of next-generation sequencing services including whole genome, exome, RNA, single-cell, amplicon and metagenomic sequencing, supported by in-house bioinformatics analysis. Platforms include Illumina, PacBio and Oxford Nanopore technologies. Novogene serves academic research institutions, pharmaceutical companies and agricultural enterprises globally.

AI-driven isoform sequencing platform for movement disorder and ageing research

Entelo Bio is an Oxford-based biotechnology company developing a proprietary single-cell isoform sequencing and AI platform to decode disease biology in conditions affecting human movement and ageing. Built on research from the University of Oxford's Botnar Institute for Musculoskeletal Sciences, the platform combines long-read RNA sequencing with machine learning to reveal hidden isoform-level biology and identify precision medicine targets. Target disease areas include chronic musculoskeletal conditions, age-related movement disorders, and rare genetic diseases.

Real-time DNA and RNA sequencing at any scale

Oxford Nanopore Technologies is a biotechnology company developing and commercialising electronic nanopore sequencing instruments and consumables for the direct analysis of DNA and RNA. Its devices range from pocket-sized portable units to high-throughput benchtop systems, enabling long-read sequencing without batching or amplification. Applications span genomics, infectious disease surveillance, clinical diagnostics and environmental monitoring, serving academic institutions, biopharma organisations and healthcare providers globally.

National genomics research and NHS whole genome sequencing

Genomics England is a government-owned organisation that partners with the NHS to deliver whole genome sequencing diagnostics and advance genomic medicine in the UK. It operates the National Genomic Research Library, providing approved researchers with access to linked genomic and clinical data to identify the causes of disease and support new treatment development. Current programmes include newborn genome sequencing, long-read sequencing in cancer, and initiatives to address genomic health inequalities.